Fundraising Fox

Kardigan

NASDAQ: KARD

Incorporated in Delaware · 3 known investors

kardigan.bio ↗

Kardigan develops targeted cardiovascular treatments through a discovery and translational research platform, with a pipeline of late-stage drug candidates aimed at functional cures for cardiovascular disease. The company integrates AI and real-world data to advance clinical development across multiple underserved cardiovascular conditions.

AI & Machine LearningBiotechHealthtechMedical Devicesin /kardigan-inc

Investors · 3

ARCH Venture PartnersChicago · $50K – $250M
Catalio Capital Management, LPNew York
T. Rowe PricereportedBaltimore

In the news